Heron Therapeutics (HRTX) EPS (Basic) (2011 - 2026)
Heron Therapeutics' (HRTX) quarterly EPS (Basic) came in at -$0.04 in Q1 2026, down 355.8% YoY from $0.02 in Q1 2025, and down 24.98% on a QoQ basis from -$0.03 in Q4 2025.
Heron Therapeutics (HRTX) EPS (Basic) (2011 - 2026) Analysis & Trends
Heron Therapeutics (HRTX) has 16 years of EPS (Basic) data on file, last reported at -$0.04 in Q1 2026.
- Quarterly EPS (Basic) fell 355.8% year-over-year to -$0.04 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.12 (down 192.62% YoY) and the FY2025 annual result came in at -$2.49, down 2612.67% from the prior year.
- EPS (Basic) slipped to -$0.04 in Q1 2026, from -$0.03 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.03 in Q4 2024 to a low of -$199.0 in Q4 2022.
- A 5-year average of -$11.86 and a median of -$0.05 in 2024 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) slumped 36665.11% — and 2025, when it jumped 141.07%.
- Tracing HRTX's EPS (Basic) over 5 years: stood at -$199.0 in 2022, then surged by 99.96% to -$0.09 in 2023, then soared by 130.75% to $0.03 in 2024, then tumbled by 217.14% to -$0.03 in 2025, then retreated by 24.98% to -$0.04 in 2026.
- The last three EPS (Basic) figures came in at -$0.04 (Q1 2026), -$0.03 (Q4 2025), and -$0.04 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Heron Therapeutics | 58.32 Mn | 15.65 Mn | 26.09 Mn | -0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.04 |
| Mar 31, 2026 | -0.04 |
| Dec 31, 2025 | -0.03 |
| Sep 30, 2025 | -0.04 |
| Jun 30, 2025 | -0.02 |
| Mar 31, 2025 | 0.02 |
| Dec 31, 2024 | 0.03 |
| Sep 30, 2024 | -0.03 |
| Jun 30, 2024 | -0.05 |
| Mar 31, 2024 | -0.04 |
| Dec 31, 2023 | -0.09 |
| Sep 30, 2023 | -0.18 |
| Jun 30, 2023 | -0.36 |
| Mar 31, 2023 | -0.28 |
| Dec 31, 2022 | -199.00 |
| Sep 30, 2022 | -0.38 |
| Jun 30, 2022 | -0.49 |
| Mar 31, 2022 | -0.62 |
| Dec 31, 2021 | -0.54 |
| Sep 30, 2021 | -0.51 |